Breast Cancer : Targets and Therapy Jernström, S, Hongisto, V, Leivonen, S, Due, E, Tadele, D, Edgren, H, Kallioniemi, O, Perälä, M, Mælandsmo, G & Sahlberg, K 2017, ' Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response ', Breast Cancer, vol. 9, A22, pp. 185-198 . https://doi.org/10.2147/BCTT.S115600
Breast Cancer Research : BCR Aure, M R, Vitelli, V, Jernström, S, Kumar, S, Krohn, M, Due, E U, Haukaas, T H, Leivonen, S-K, Vollan, H K M, Lüders, T, Rødland, E, Vaske, C J, Zhao, W, Møller, E K, Nord, S, Giskeødegård, G F, Bathen, T F, Caldas, C, Tramm, T, Alsner, J, Overgaard, J, Geisler, J, Bukholm, I R K, Naume, B, Schlichting, E, Sauer, T, Mills, G B, Kåresen, R, Mælandsmo, G M, Lingjærde, O C, Frigessi, A, Kristensen, V N, Børresen-Dale, A-L, Sahlberg, K K & OSBREAC 2017, ' Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome ', Breast Cancer Research, vol. 19, no. 1, 44 . https://doi.org/10.1186/s13058-017-0812-y Breast Cancer Research Breast Cancer Research, Vol 19, Iss 1, Pp 1-18 (2017)
Leivonen, S-K, Sahlberg, K K, Mäkelä, R, Due, E U, Kallioniemi, O, Børresen-Dale, A-L & Perälä, M 2014, ' High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth ', Molecular Oncology, vol. 8, no. 1, pp. 93-104 . https://doi.org/10.1016/j.molonc.2013.10.001
Kleivi Sahlberg, K, Hongisto, V, Edgren, H, Mäkelä, R, Hellström, K, Due, E U, Moen Vollan, H K, Sahlberg, N, Wolf, M, Børresen-Dale, A-L, Perälä, M & Kallioniemi, O 2013, ' The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells ', Molecular Oncology, vol. 7, no. 3, pp. 392-401 . https://doi.org/10.1016/j.molonc.2012.10.012